• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常见的癌症突变 R175H 和 R273H 使 p53 DNA 结合域趋向于易于聚集的构象。

Common cancer mutations R175H and R273H drive the p53 DNA-binding domain towards aggregation-prone conformations.

机构信息

Department of Physics, State Key Laboratory of Surface Physics, and Key Laboratory for Computational Physical Sciences (Ministry of Education), Multiscale Research Institute of Complex Systems, Fudan University, Shanghai 200438, People's Republic of China.

出版信息

Phys Chem Chem Phys. 2020 May 7;22(17):9225-9232. doi: 10.1039/c9cp06671c. Epub 2020 Apr 20.

DOI:10.1039/c9cp06671c
PMID:32307496
Abstract

The p53 protein is a tumor suppressor and the most often mutated protein in human cancers. Recent studies reported that p53 mutants, including two of the common cancer mutants (R175H and R273H), are more prone to aggregation than wild type (WT) p53 and their pathological aggregation can lead to diverse cancers. However, the underlying molecular mechanism is poorly understood. Herein, we investigated the structural and dynamic properties of R175H and R273H mutants of the p53 core domain (p53C) by performing extensive all-atom molecular dynamics simulations. We found that both R175H and R273H mutants exhibit a well preserved β-sheet structure, but a larger hydrophobic surface area and higher loop flexibility than WT p53C. These conformational properties are consistent with the structural features of aggregation-prone molten-globule states. Our data also provide the details on how the two mutations lead to an increased flexibility of loop2. Moreover, using dynamic network analysis, we identified the allosteric path through which the R273H mutation induces an increased flexibility of the distant N-terminal region of loop2. These results provide mechanistic insights into the high aggregation propensities of R175H and R273H mutants.

摘要

p53 蛋白是一种肿瘤抑制因子,也是人类癌症中最常发生突变的蛋白。最近的研究报告称,p53 突变体,包括两种常见的癌症突变体(R175H 和 R273H),比野生型(WT)p53 更容易聚集,它们的病理性聚集可能导致多种癌症。然而,其潜在的分子机制尚不清楚。在此,我们通过进行广泛的全原子分子动力学模拟,研究了 p53 核心域(p53C)中 R175H 和 R273H 突变体的结构和动态特性。我们发现,R175H 和 R273H 突变体均表现出良好的β-折叠结构,但与 WT p53C 相比,它们具有更大的疏水性表面积和更高的环灵活性。这些构象特性与易于聚集的无规卷曲状态的结构特征一致。我们的数据还提供了关于这两种突变如何导致环 2 的灵活性增加的详细信息。此外,通过动态网络分析,我们确定了 R273H 突变诱导环 2 远 N 端区域灵活性增加的变构途径。这些结果为 R175H 和 R273H 突变体高聚集倾向提供了机制见解。

相似文献

1
Common cancer mutations R175H and R273H drive the p53 DNA-binding domain towards aggregation-prone conformations.常见的癌症突变 R175H 和 R273H 使 p53 DNA 结合域趋向于易于聚集的构象。
Phys Chem Chem Phys. 2020 May 7;22(17):9225-9232. doi: 10.1039/c9cp06671c. Epub 2020 Apr 20.
2
Molecular dynamics study on the inhibition mechanisms of ReACp53 peptide for p53-R175H mutant aggregation.分子动力学研究 ReACp53 肽对 p53-R175H 突变体聚集的抑制机制。
Phys Chem Chem Phys. 2021 Oct 20;23(40):23032-23041. doi: 10.1039/d1cp03094a.
3
Oncogenic R248W mutation induced conformational perturbation of the p53 core domain and the structural protection by proteomimetic amyloid inhibitor ADH-6.致癌性 R248W 突变诱导 p53 核心结构域构象改变,并被拟肽淀粉样抑制剂 ADH-6 稳定结构。
Phys Chem Chem Phys. 2024 Jul 24;26(29):20068-20086. doi: 10.1039/d4cp02046d.
4
Differential effect of plakoglobin in restoring the tumor suppressor activities of p53-R273H vs. p53-R175H mutants. plakoglobin 对 p53-R273H 与 p53-R175H 突变体肿瘤抑制活性的恢复作用存在差异。
PLoS One. 2024 Oct 3;19(10):e0306705. doi: 10.1371/journal.pone.0306705. eCollection 2024.
5
Aggregation-primed molten globule conformers of the p53 core domain provide potential tools for studying p53C aggregation in cancer.聚集引发的 p53 核心结构域的熔融球蛋白构象为研究癌症中 p53C 聚集提供了潜在的工具。
J Biol Chem. 2018 Jul 20;293(29):11374-11387. doi: 10.1074/jbc.RA118.003285. Epub 2018 May 31.
6
Butein inhibits cancer cell growth by rescuing the wild-type thermal stability of mutant p53.刺槐素通过挽救突变型 p53 的野生型热稳定性来抑制癌细胞生长。
Biomed Pharmacother. 2023 Jul;163:114773. doi: 10.1016/j.biopha.2023.114773. Epub 2023 May 8.
7
Structure and Function of p53-DNA Complexes with Inactivation and Rescue Mutations: A Molecular Dynamics Simulation Study.具有失活和挽救突变的p53-DNA复合物的结构与功能:分子动力学模拟研究
PLoS One. 2015 Aug 5;10(8):e0134638. doi: 10.1371/journal.pone.0134638. eCollection 2015.
8
Insights into Allosteric Mechanisms of the Lung-Enriched p53 Mutants V157F and R158L.肺组织特异性 p53 突变体 V157F 和 R158L 的别构机制研究进展。
Int J Mol Sci. 2022 Sep 3;23(17):10100. doi: 10.3390/ijms231710100.
9
Elucidating the Mechanisms of R248Q Mutation-Enhanced p53 Aggregation and Its Inhibition by Resveratrol.阐明 R248Q 突变增强 p53 聚集的机制及其被白藜芦醇抑制的机制。
J Phys Chem B. 2023 Sep 14;127(36):7708-7720. doi: 10.1021/acs.jpcb.3c04700. Epub 2023 Sep 4.
10
Mutations in DNA binding domain of p53 impede RSL1D1-p53 interaction to escape from degradation in human colorectal cancer cells.p53 DNA 结合域的突变可阻碍 RSL1D1-p53 相互作用,从而逃避人结直肠癌细胞的降解。
Exp Cell Res. 2022 Aug 1;417(1):113211. doi: 10.1016/j.yexcr.2022.113211. Epub 2022 May 18.

引用本文的文献

1
A base editing platform for the correction of cancer driver mutations unmasks conserved p53 transcription programs.用于纠正癌症驱动基因突变的碱基编辑平台揭示了保守的p53转录程序。
Genome Biol. 2025 Jul 22;26(1):217. doi: 10.1186/s13059-025-03667-7.
2
Lipogenic enzyme FASN promotes mutant p53 accumulation and gain-of-function through palmitoylation.脂肪生成酶FASN通过棕榈酰化促进突变型p53的积累和功能获得。
Nat Commun. 2025 Feb 19;16(1):1762. doi: 10.1038/s41467-025-57099-9.
3
Emerging regulatory mechanisms and functions of biomolecular condensates: implications for therapeutic targets.
生物分子凝聚物的新兴调控机制与功能:对治疗靶点的启示
Signal Transduct Target Ther. 2025 Jan 6;10(1):4. doi: 10.1038/s41392-024-02070-1.
4
Advancements in -Based Anti-Tumor Gene Therapy Research.基于 的抗肿瘤基因治疗研究进展。
Molecules. 2024 Nov 11;29(22):5315. doi: 10.3390/molecules29225315.
5
Bioinformatic Characterization of the Functional and Structural Effect of Single Nucleotide Mutations in Patients with High-Grade Glioma.高级别胶质瘤患者单核苷酸突变功能和结构效应的生物信息学特征分析
Biomedicines. 2024 Oct 9;12(10):2287. doi: 10.3390/biomedicines12102287.
6
The Inhibition Effect of Epigallocatechin-3-Gallate on the Co-Aggregation of Amyloid-β and Human Islet Amyloid Polypeptide Revealed by Replica Exchange Molecular Dynamics Simulations.表没食子儿茶素没食子酸酯通过 replica 交换分子动力学模拟对淀粉样β和人胰岛淀粉样多肽共聚集的抑制作用。
Int J Mol Sci. 2024 Jan 29;25(3):1636. doi: 10.3390/ijms25031636.
7
Targeting mutant p53 stabilization for cancer therapy.靶向突变型p53稳定化用于癌症治疗。
Front Pharmacol. 2023 Jul 12;14:1215995. doi: 10.3389/fphar.2023.1215995. eCollection 2023.
8
Molecular Mechanism of Tau Misfolding and Aggregation: Insights from Molecular Dynamics Simulation.tau 蛋白错误折叠和聚集的分子机制:来自分子动力学模拟的见解。
Curr Med Chem. 2024;31(20):2855-2871. doi: 10.2174/0929867330666230409145247.
9
Molecular Management of High-Grade Serous Ovarian Carcinoma.高级别浆液性卵巢癌的分子管理
Int J Mol Sci. 2022 Nov 9;23(22):13777. doi: 10.3390/ijms232213777.
10
Recent findings on the role of wild-type and mutant p53 in cancer development and therapy.野生型和突变型p53在癌症发生发展及治疗中作用的最新研究发现。
Front Mol Biosci. 2022 Sep 26;9:903075. doi: 10.3389/fmolb.2022.903075. eCollection 2022.